<DOC>
	<DOCNO>NCT02126241</DOCNO>
	<brief_summary>This proposal aim evaluate add clinical echocardiographic benefit use non-invasive impedance-based cardiac output measurement system ( NICaS ) optimize atrio-ventricular inter-ventricular delay chronic ( 6 month ) CRT recipient .</brief_summary>
	<brief_title>Non-Invasive Cardiac Output Measurement CRT Optimization</brief_title>
	<detailed_description>1 . Introduction Cardiac resynchronization therapy ( CRT ) efficient treatment heart failure ( HF ) patient leave ventricular ( LV ) systolic dysfunction wide QRS . It associate improved exercise capacity , quality life leave ventricular ejection fraction , well reverse remodeling , mitral regurgitation reduction , mortality reduction . Predicting response CRT important 30 % patient minimal clinical improvement follow CRT . Several parameter show influence response follow implantation . Some relate patient ' characteristic include underlying heart disease , comorbidities arrhythmias , type severity conduction disorder , presence degree dyssynchrony , presence extent scar tissue functional myocardial reserve . Others associate technical aspect , include electrical anatomical positioning LV lead , program mode percentage effective bi-ventricular pacing . Optimization atrio-ventricular ( AV ) delay inter-ventricular ( VV ) delay use maximize CRT benefit , routinely recommend current guideline . Standard optimization perform echocardiography guidance - time resource consume method . Other non-invasive method , impedance cardiography , use AV delay optimization . 2 . Rationale CRT optimization use NICaS The non-invasive cardiac system ( NICaS ) whole-body bioimpedance measurement method allow real-time cardiac output ( CO ) assessment . It FDA approve assist diagnosis , monitor care management patient congestive heart failure well cardiac pacemaker optimization . Clinical trial show utility follow-up outpatient monitoring chronic heart failure , monitoring patient heart failure pulmonary hypertension . NICaS sensitive enough detect real-time small change CO. Based NICaS measure CO change follow AV VV delay modification , small series support use CRT optimization clinical setting , suggest may associate reduction non-responder rate . 3 . Hypothesis We hypothesize use NICaS optimization AV VV delay chronic ( 6 month ) CRT recipient may result add clinical echocardiographic benefit . 4 . Specific Aims 1 . Identify CRT recipients prone benefit follow CRT optimization , find predictor ( clinical , ECG , echocardiographic , hemodynamic ) significant cardiac output improvement NICaS guide CRT optimization 2 . Correlate degree cardiac output improvement ( measure NICaS ) NICaS guide CRT optimization , clinical echocardiographic change 6 month 5 . Timeline : I . At Inclusion I.A . Baseline assessment . Patients include study benefit follow baseline assessment , perform outpatient setting : 1 . Clinical evaluation : 1. history ; 2 . NYHA class ; six-minute walk test ( 6MWT ) ; Minnesota Living Heart Failure questionnaire quality life ( QoL ) ; 3. status follow CRT ( responder/non-responder ) ; 4. physical evaluation ; 5. current medication 2 . ECG 3 . Device interrogation 4 . Transthoracic echocardiography ( include dyssynchrony parameter ) I.B . NICaS protocol optimal AV VV delay assessment . After baseline assessment complete , patient benefit NICaS hemodynamic assessment CRT program accord NICaS guide optimal AV VV delay . ( NICaS protocol optimal AV VV delay measurement - see Interventions ) I.C . After NICaS guide CRT programming , patient perform 6MWT II . At 6 month follow-up . At 6 month , patient benefit following evaluation : 1 . Clinical : NYHA class , 6MWT , Minnesota Living Heart Failure questionnaire quality life , current medication 2 . ECG 3 . Device interrogation 4 . Transthoracic echocardiography</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients implant CRT device least 6 month , concordance AHA/ACC ESC/EHRA Guidelines ( Class I II ) CRT implantation NYHA class I III heart failure Stable sinus rhythm Biventricular pacing â‰¥ 90 % Patient provide informed consent . NYHA class IV heart failure Permanent persistent atrial fibrillation Biventricular pacing &lt; 90 % Inability perform sixminute walk test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiac Resyncronization Therapy</keyword>
	<keyword>Optimization</keyword>
	<keyword>Non-invasive cardiac system</keyword>
	<keyword>Impedance measure cardiac output</keyword>
</DOC>